« Back to Record
Eggermont, A., Suciu, S., Testori, A., Santinami, M., Kruit, W. H., Marsden, J., Punt, C., Sales, F., Dummer, R., Robert, C., Schadendorf, D., Patel, P., de Schaetzen, G., Spatz, A., & Keilholz, U. (2012). Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma. Journal of clinical oncology, 30(31), 3810-3818. doi:10.1200/JCO.2011.41.3799
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/144686



